SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-138390
Filing Date
2024-05-14
Accepted
2024-05-14 17:19:51
Documents
5
Effectiveness Date
2024-05-14

Document Format Files

Seq Description Document Type Size
1 S-8 d836127ds8.htm S-8 39517
2 EX-5.1 d836127dex51.htm EX-5.1 8104
3 EX-23.1 d836127dex231.htm EX-23.1 1204
4 EX-FILING FEES d836127dexfilingfees.htm EX-FILING FEES 15525
5 GRAPHIC g836127dsp.jpg GRAPHIC 3381
  Complete submission text file 0001193125-24-138390.txt   70179
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279405 | Film No.: 24945799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)